company background image
VTI logo

Visioneering Technologies ASX:VTI Stock Report

Last Price

AU$0.14

Market Cap

AU$7.7m

7D

0%

1Y

-34.9%

Updated

21 Nov, 2024

Data

Company Financials

Visioneering Technologies, Inc.

ASX:VTI Stock Report

Market Cap: AU$7.7m

VTI Stock Overview

A medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific. More details

VTI fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Visioneering Technologies, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Visioneering Technologies
Historical stock prices
Current Share PriceAU$0.14
52 Week HighAU$0.27
52 Week LowAU$0.092
Beta1.73
11 Month Change21.74%
3 Month Change40.00%
1 Year Change-34.88%
33 Year Change-84.70%
5 Year Change-98.00%
Change since IPO-99.69%

Recent News & Updates

Recent updates

Health Check: How Prudently Does Visioneering Technologies (ASX:VTI) Use Debt?

Sep 23
Health Check: How Prudently Does Visioneering Technologies (ASX:VTI) Use Debt?

Shareholder Returns

VTIAU Medical EquipmentAU Market
7D0%0.5%1.5%
1Y-34.9%14.2%17.2%

Return vs Industry: VTI underperformed the Australian Medical Equipment industry which returned 14.2% over the past year.

Return vs Market: VTI underperformed the Australian Market which returned 17.2% over the past year.

Price Volatility

Is VTI's price volatile compared to industry and market?
VTI volatility
VTI Average Weekly Movement15.7%
Medical Equipment Industry Average Movement9.1%
Market Average Movement8.6%
10% most volatile stocks in AU Market17.3%
10% least volatile stocks in AU Market3.4%

Stable Share Price: VTI's share price has been volatile over the past 3 months compared to the Australian market.

Volatility Over Time: VTI's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of Australian stocks.

About the Company

FoundedEmployeesCEOWebsite
2008n/aJuan Aragonwww.vtivision.com

Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific. Its flagship product is NaturalVue, a multifocal 1-day contact lens for adults with presbyopia and children with myopia. The company was incorporated in 2008 and is headquartered in Alpharetta, Georgia.

Visioneering Technologies, Inc. Fundamentals Summary

How do Visioneering Technologies's earnings and revenue compare to its market cap?
VTI fundamental statistics
Market capAU$7.74m
Earnings (TTM)-AU$5.34m
Revenue (TTM)AU$13.29m

0.6x

P/S Ratio

-1.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VTI income statement (TTM)
RevenueUS$8.64m
Cost of RevenueUS$5.97m
Gross ProfitUS$2.67m
Other ExpensesUS$6.15m
Earnings-US$3.47m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.063
Gross Margin30.93%
Net Profit Margin-40.22%
Debt/Equity Ratio0%

How did VTI perform over the long term?

See historical performance and comparison